179 related articles for article (PubMed ID: 31601105)
1. Untargeted Lipidomics Reveals Specific Lipid Abnormalities in Nonfunctioning Human Pituitary Adenomas.
Hu C; Zhou Y; Feng J; Zhou S; Li C; Zhao S; Shen Y; Hong L; Xuan Q; Liu X; Li Q; Wang X; Zhang Y; Xu G
J Proteome Res; 2020 Jan; 19(1):455-463. PubMed ID: 31601105
[TBL] [Abstract][Full Text] [Related]
2. MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
Uraki S; Ariyasu H; Doi A; Takeshima K; Morita S; Inaba H; Furuta H; Fukuhara N; Inoshita N; Nishioka H; Nakao N; Yamada S; Akamizu T
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325698
[TBL] [Abstract][Full Text] [Related]
3. UPLC-MS/MS-based Lipidomic Profiles Revealed Aberrant Lipids Associated with Invasiveness of Silent Corticotroph Adenoma.
Wang Z; Guo X; Wang W; Gao L; Bao X; Feng M; Lian W; Zhu H; Xing B
J Clin Endocrinol Metab; 2021 Jan; 106(1):e273-e287. PubMed ID: 33031533
[TBL] [Abstract][Full Text] [Related]
4. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
[TBL] [Abstract][Full Text] [Related]
5. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the cell adhesion molecule claudin-9 is associated with invasion in pituitary oncocytomas.
Hong L; Wu Y; Feng J; Yu S; Li C; Wu Y; Li Z; Cao L; Wang F; Zhang Y
Hum Pathol; 2014 Dec; 45(12):2423-9. PubMed ID: 25281028
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and ultrastructural study of clinically nonfunctioning pituitary adenomas.
Zhao D; Tomono Y; Tsuboi K; Nose T
Neurol Med Chir (Tokyo); 2000 Sep; 40(9):453-6; discussion 456-7. PubMed ID: 11021076
[TBL] [Abstract][Full Text] [Related]
8. Alterations in CD8
Huang X; Xu J; Wu Y; Sheng L; Li Y; Zha B; Sun T; Yang J; Zang S; Liu J
Pathol Oncol Res; 2021; 27():598887. PubMed ID: 34257554
[TBL] [Abstract][Full Text] [Related]
9. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
[TBL] [Abstract][Full Text] [Related]
10. Null cell adenomas and oncocytomas of the pituitary gland.
Holm R
Pathol Res Pract; 1995 May; 191(4):348-52. PubMed ID: 7479351
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas.
He Z; Chen L; Hu X; Tang J; He L; Hu J; Fei F; Wang Q
Endocr J; 2019 Aug; 66(8):709-722. PubMed ID: 31061247
[TBL] [Abstract][Full Text] [Related]
12. Proteomic Profiles Associated With Postsurgical Progression in Nonfunctioning Pituitary Adenomas.
Hallén T; Johannsson G; Thorsell A; Olsson DS; Örndal C; Engvall A; Jacobson F; Widgren A; Bergquist J; Skoglund T
J Clin Endocrinol Metab; 2024 May; 109(6):1485-1493. PubMed ID: 38157275
[TBL] [Abstract][Full Text] [Related]
13. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
14. Gonadotroph adenoma with secondary hypersecretion of testosterone.
Chamoun R; Layfield L; Couldwell WT
World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic Transsphenoidal Surgery Outcomes in 331 Nonfunctioning Pituitary Adenoma Cases After a Single Surgeon Learning Curve.
Kim JH; Lee JH; Lee JH; Hong AR; Kim YJ; Kim YH
World Neurosurg; 2018 Jan; 109():e409-e416. PubMed ID: 29017983
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas.
Grande IPP; Amorim PVGH; Freire ACTB; Jallad RS; Musolino NR; Cescato VA; da Silva GO; Bronstein MD; Trarbach EB
Pituitary; 2018 Aug; 21(4):355-361. PubMed ID: 29564694
[TBL] [Abstract][Full Text] [Related]
17. Urocortin expression in human pituitary gland and pituitary adenoma.
Iino K; Sasano H; Oki Y; Andoh N; Shin RW; Kitamoto T; Totsune K; Takahashi K; Suzuki H; Nagura H; Yoshimi T
J Clin Endocrinol Metab; 1997 Nov; 82(11):3842-50. PubMed ID: 9360550
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of TGF-β RII expression is correlated with tumor growth and invasion in non-functioning pituitary adenomas.
Gu YH; Feng YG
J Clin Neurosci; 2018 Jan; 47():264-268. PubMed ID: 29031543
[TBL] [Abstract][Full Text] [Related]
19. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Primary Management of Patients With Nonfunctioning Pituitary Adenomas.
Lucas JW; Bodach ME; Tumialan LM; Oyesiku NM; Patil CG; Litvack Z; Aghi MK; Zada G
Neurosurgery; 2016 Oct; 79(4):E533-5. PubMed ID: 27635961
[TBL] [Abstract][Full Text] [Related]
20. Changes in DNA 5-Hydroxymethylcytosine Levels and the Underlying Mechanism in Non-functioning Pituitary Adenomas.
Xu Y; Niu Y; Deng K; Pan H; Feng F; Gong F; Tong WM; Chen S; Lu L; Wang R; You H; Yao Y; Zhu H
Front Endocrinol (Lausanne); 2020; 11():361. PubMed ID: 32774324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]